GFACX
Price
$70.96
Change
+$0.29 (+0.41%)
Updated
Jul 16 closing price
Net Assets
322.72B
LGLQX
Price
$48.88
Change
+$0.13 (+0.27%)
Updated
Jul 16 closing price
Net Assets
7.4B
Interact to see
Advertisement

GFACX vs LGLQX

Header iconGFACX vs LGLQX Comparison
Open Charts GFACX vs LGLQXBanner chart's image
American Funds Growth Fund of Amer C
Price$70.96
Change+$0.29 (+0.41%)
VolumeN/A
Net Assets322.72B
Lord Abbett Growth Leaders R2
Price$48.88
Change+$0.13 (+0.27%)
VolumeN/A
Net Assets7.4B
GFACX vs LGLQX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GFACX vs. LGLQX commentary
Jul 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a StrongBuy and LGLQX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 323B vs. LGLQX (7.4B). GFACX (0.00) and LGLQX (0.00) have matching dividends . GFACX was incepted earlier than LGLQX: GFACX (24 years) vs LGLQX (14 years). GFACX (1.36) is less costly to investors than LGLQX (1.25). LGLQX is a more actively managed with annual turnover of: 94.00 vs. GFACX (25.00). LGLQX has a lower initial minimum investment than GFACX: LGLQX (0) vs GFACX (250). LGLQX annual gain was more profitable for investors over the last year : 23.11 vs. GFACX (7.11). GFACX return over 5 years is better than : 35.91 vs. LGLQX (32.26).
GFACXLGLQXGFACX / LGLQX
Total Expense Ratio1.361.25109%
Annual Report Gross Expense Ratio1.361.25109%
Fund Existence24 years14 years-
Gain YTD11.2927.854144%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets323B7.4B4,363%
Annual Yield % from dividends0.000.00-
Returns for 1 year7.1123.1131%
Returns for 3 years52.0184.3862%
Returns for 5 years35.9132.26111%
Returns for 10 years63.3196.6566%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IKT1.860.06
+3.33%
Inhibikase Therapeutics
MKC71.380.63
+0.89%
McCormick & Company
VTS22.940.06
+0.26%
Vitesse Energy
ADN1.95N/A
N/A
Advent Technologies Holdings Inc.
BTE1.84-0.04
-2.13%
Baytex Energy Corp